Multicenter randomized phase III study of the cardioprotective effect of dexrazoxane (Cardioxane®) in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapyM. Marty, V. Stahalova, Bernardo L. Rapoport et al.|Annals of Oncology|2006Cited by 197
Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast CancerJosé Baselga, Frederico Costa, J. G. M. Segalla et al.|Journal of Clinical Oncology|2012Cited by 163